Open access
Open access
Powered by Google Translator Translator

Head and Neck Surgery

M-A: Advanced computed tomographic localization techniques for primary hyperparathyroidism.

6 Apr, 2022 | 09:57h | UTC

Advanced Computed Tomographic Localization Techniques for Primary Hyperparathyroidism: A Systematic Review and Meta-analysis – JAMA Otolaryngology-Head & Neck Surgery (link to abstract – $ for full-text)

 


Podcast: Deep dive into deep neck infections in children.

31 Mar, 2022 | 07:57h | UTC

#47: Deep Dive into Deep Neck Infections with Dr. Travis Crook – The Cribsiders

 


SEOM-TTCC clinical guideline in nasopharynx cancer.

25 Mar, 2022 | 08:20h | UTC

SEOM-TTCC clinical guideline in nasopharynx cancer (2021) – Clinical and Translational Oncology

 


Consensus Statement | Minimally-invasive treatments for benign thyroid nodules: recommendations for information to patients and referring physicians.

24 Mar, 2022 | 08:42h | UTC

Minimally-invasive treatments for benign thyroid nodules: recommendations for information to patients and referring physicians by the Italian Minimally-Invasive Treatments of the Thyroid group – Endocrine

 


Position Paper | Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy.

24 Mar, 2022 | 08:34h | UTC

Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy – A German position paper from Surgery and Nuclear Medicine – Nuclear Medicine

Related: RCT: In patients with low-risk thyroid cancer, thyroidectomy without ablation radioiodine was noninferior to thyroidectomy with ablation radioiodine at 3 years.

 


RCT: Elective upper-neck vs. whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma.

9 Mar, 2022 | 08:17h | UTC

Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial – The Lancet Oncology (link to abstract – $ for full-text)

Commentaries:

Elective Upper-Neck vs Whole-Neck Irradiation in Nasopharyngeal Carcinoma – The ASCO Post

Lower Neck-Sparing RT Succeeds in Nasopharyngeal Carcinoma— Phase III trial also shows that upper-neck irradiation leads to fewer late toxicities – MedPage Today (link to abstract – $ for full-text)

 


RCT: In operated patients with head and neck cancer, chemoradiotherapy with weekly cisplatin is noninferior to 3-weekly cisplatin and is associated with reduced toxicity.

3 Mar, 2022 | 08:11h | UTC

Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial – Journal of Clinical Oncology

 

Commentary from the author on Twitter

 


HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management.

1 Mar, 2022 | 08:30h | UTC

HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management – Nature Reviews Clinical Oncology (if the link is paywalled, try this one)

 


Consensus Statement: Head and neck cancer survivorship.

16 Feb, 2022 | 08:49h | UTC

Head and neck cancer survivorship consensus statement from the American Head and Neck Society – Laryngoscope Investigative Otolaryngology

Related:

Head and Neck Cancer Survivorship Care Guideline

American Cancer Society Head and Neck Cancer Survivorship Care Guideline

 


ED management of the post-laryngectomy patient.

13 Feb, 2022 | 21:44h | UTC

ED Management of the Post-Laryngectomy Patient – emDocs

 


ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?

11 Feb, 2022 | 08:23h | UTC

2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer? – European Thyroid Journal

 


Systematic Review: Chemotherapy for the treatment of oral cavity and oropharyngeal cancer.

13 Jan, 2022 | 08:14h | UTC

Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy – Cochrane Library

Summary: Chemotherapy for mouth and throat cancer – Cochrane Library

 


Choosing Wisely for Thyroid Conditions: Ten things clinicians and patients should question – “Do not order thyroid ultrasound for nodule detection in patients without thyroid anatomic anomalies on clinical examination”.

9 Nov, 2021 | 01:11h | UTC

Choosing Wisely for Thyroid Conditions: Recommendations of the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism

See complete lists of low-value practices: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia AND Choosing Wisely Canada

 


RCT: Prophylactic steroids prevent hypocalcemia and voice dysfunction in patients undergoing thyroidectomy.

15 Sep, 2021 | 08:44h | UTC

Use of Prophylactic Steroids to Prevent Hypocalcemia and Voice Dysfunction in Patients Undergoing Thyroidectomy: A Randomized Clinical Trial – JAMA Otolaryngology – Head & Neck Surgery (link to abstract – $ for full-text)

Author interview: Prophylactic Steroids for Postthyroidectomy Hypocalcemia and Voice Dysfunction

Commentary: IV Steroid Before Thyroidectomy Prevents Complications — One dose of dexamethasone reduced hypocalcemia, voice issues – MedPage Today (free registration required)

 

Commentary on Twitter

 


ASCO Guideline: Salivary gland hypofunction and/or xerostomia induced by nonsurgical cancer therapies.

19 Aug, 2021 | 08:50h | UTC

Salivary Gland Hypofunction and/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO/MASCC/ASCO Guideline – Journal of Clinical Oncology

 


Review: Initial management of blunt and penetrating neck trauma.

17 Aug, 2021 | 08:40h | UTC

Initial management of blunt and penetrating neck trauma – BJA Education

 


Clinical Picture: Mucormycosis after COVID-19 in a patient with diabetes.

6 Aug, 2021 | 10:09h | UTC

Mucormycosis after COVID-19 in a patient with diabetes – The Lancet

Related:

COVID-19 and mucormycosis superinfection: the perfect storm.

ECMM/ISHAM recommendations for clinical management of COVID -19 associated mucormycosis in low- and middle-income countries.

The “Black Fungus” in India: The Emerging Syndemic of COVID-19–Associated Mucormycosis – careful use of antibiotics and corticosteroids and closely monitoring blood glucose levels are some of the strategies suggested by the authors.

Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India – Uncontrolled diabetes mellitus was the most common underlying disease; improper glucocorticoid use was independently associated with the disease.

Opinion | “Doctors have been blamed for the rise in black fungus in India, but the COVID treatment guidelines could be contributing” – improper use of antibiotics and higher than usual doses of corticosteroids may be contributing to the emergence of mucormycosis and other fungal co-infections.

What is mucormycosis, the fungal infection affecting COVID patients in India?

[Preprint] The Emergence of COVID-19 Associated Mucormycosis: Analysis of Cases From 18 Countries.

Mucormycosis: The ‘black fungus’ maiming Covid patients in India

Global Guideline for the Diagnosis and Management of Mucormycosis

 


Global burden of cancer attributable to alcohol consumption – “Globally, an estimated 741.300, or 4·1% of all new cases of cancer in 2020 were attributable to alcohol consumption”.

14 Jul, 2021 | 11:07h | UTC

Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study – The Lancet Oncology

News release: Alcohol consumption linked to more than 740,000 new cancer cases in 2020 – The Lancet

Commentaries: Alcohol caused 740,000 cancer cases globally last year – study – The Guardian AND Expert reaction to study of alcohol and cancer – Science Media Centre

 


M-A: Direct comparison of preoperative imaging modalities for localization of primary hyperparathyroidism – “choline PET-CT would be the best preoperative imaging modality for localization of primary hyperparathyroidism”.

6 Jun, 2021 | 23:40h | UTC

Direct Comparison of Preoperative Imaging Modalities for Localization of Primary Hyperparathyroidism: A Systematic Review and Network Meta-analysis –

JAMA Otolaryngology – Head & Neck Surgery (free for a limited period)

Invited commentary: Localization Studies for Parathyroid Surgery (free for a limited period)

 


ASCO Guideline: Management of Salivary Gland Malignancy

28 Apr, 2021 | 08:13h | UTC

Management of Salivary Gland Malignancy: ASCO Guideline – Journal of Clinical Oncology

 


Survey: Despite guideline recommendations, many patients with low-risk thyroid cancer continue to be treated with suppressive doses of thyroid hormone

23 Apr, 2021 | 08:13h | UTC

TSH Suppression for Papillary Thyroid Cancer: A Physician Survey Study – Thyroid (link to abstract – $ for full-text)

 

Commentary on Twitter

 


RCT: Atenolol has similar efficacy as propranolol with fewer adverse events in the treatment of problematic infantile hemangiomas

20 Apr, 2021 | 05:32h | UTC

Efficacy and Safety of Propranolol vs Atenolol in Infants With Problematic Infantile Hemangiomas: A Randomized Clinical Trial – JAMA Otolaryngology-Head & Neck Surgery (link to abstract – $ for full-text)

 


Guidelines for Management of Patients with Anaplastic Thyroid Cancer

20 Apr, 2021 | 05:24h | UTC

2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer – Thyroid

Commentary: ATA Issues Guidelines for Managing Anaplastic Thyroid Cancer – HealthDay

 


M-A: Chemotherapy and radiotherapy in locally advanced head and neck cancer

15 Apr, 2021 | 06:29h | UTC

Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis – The Lancet Oncology

 

Commentary on Twitter

 


Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery

23 Mar, 2021 | 02:33h | UTC

SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery – Anaesthesia

Related: Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk – Anaesthesia

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.